Abstract
Purpose
Our aim was to describe the incidence and sites of metastatic chordomas and show their characteristic computed tomography (CT) and magnetic resonance (MR) findings.
Materials and methods
One hundred ninety-eight chordoma patients were registered in the institutional database and were followed up with CT and MR examinations for periods ranging from 1 to 158 months. Clinical features and CT and MR findings of metastatic chordomas were analyzed by two radiologists.
Results
We counted 86 metastatic sites in 49 of 198 patients. The incidence of metastasis was 24.7 %. Sites of metastases were bone, lung, liver, lymph node, muscle, skin, pleura, cerebellum, cardiac muscle, pericardium, and adrenal gland. Duration from the diagnosis to the first detection of metastasis ranged from 0 to 600 months, with an average of 45.0 months. Osteolytic lesions were most common bone metastases, but osteosclerotic metastasis was also encountered. Metastatic chordoma showed very high intensity on diffusion-weighted (DW) images in 29 of 31 patients.
Conclusion
Metastases of chordoma are not rare and may occur several years after primary lesion presentation. The high intensity of DW images is characteristic and helpful for detecting metastatic chordoma.
Similar content being viewed by others
References
Chambers PW, Schwinn CP. Chordoma. A clinicopathologic study of metastasis. Am J Clin Pathol. 1979;72(5):765–76.
Murphey MD, Andrews CL, Flemming DJ, Temple HT, Smith WS, Smirniotopoulos JG. From the archives of the AFIP. Primary tumors of the spine: radiologic pathologic correlation. Radiographics. 1996;16(5):1131–58.
Bjornsson J, Wold LE, Ebersold MJ, Laws ER. Chordoma of the mobile spine. A clinicopathologic analysis of 40 patients. Cancer. 1993;71(3):735–40.
Sopta J, Tulic G, Mijucic V, Mamontov P, Mandic N. Solitary lymph node metastasis without local recurrence of primary chordoma. Eur Spine J. 2009;18(Suppl 2):191–5.
Ruiz HA, Goldberg LH, Humphreys TR, Blacklock JB. Cutaneous metastasis of chordoma. Dermatol Surg. 2000;26(3):259–62.
Fagundes MA, Hug EB, Liebsch NJ, Daly W, Efird J, Munzenrider JE. Radiation therapy for chordomas of the base of skull and cervical spine: patterns of failure and outcome after relapse. Int J Radiat Oncol Biol Phys. 1995;33(3):579–84.
Crapanzano JP, Ali SZ, Ginsberg MS, Zakowski MF. Chordoma: a cytologic study with histologic and radiologic correlation. Cancer. 2001;93(1):40–51.
Stacchiotti S, Casali PG, Lo Vullo S, Mariani L, Palassini E, Mercuri M, et al. Chordoma of the mobile spine and sacrum: a retrospective analysis of a series of patients surgically treated at two referral centers. Ann Surg Oncol. 2010;17(1):211–9.
Heffelfinger MJ, Dahlin DC, MacCarty CS, Beabout JW. Chordomas and cartilaginous tumors at the skull base. Cancer. 1973;32(2):410–20.
Meyer JE, Lepke RA, Lindfors KK, Pagani JJ, Hirschy JC, Hayman LA, et al. Chordomas: their CT appearance in the cervical, thoracic and lumbar spine. Radiology. 1984;153(3):693–6.
Erdem E, Angtuaco EC, Van Hemert R, Park JS, Al-Mefty O. Comprehensive review of intracranial chordoma. Radiographics. 2003;23(4):995–1009.
Kamada T, Tsujii H, Tsuji H, Yanagi T, Mizoe JE, Miyamoto T, et al. Efficacy and safety of carbon ion radiotherapy in bone and soft tissue sarcomas. J Clin Oncol. 2002;20(22):4466–71.
Ozono S, Miyao N, Igarashi T, Marumo K, Nakazawa H, Fukuda M, et al. Tumor doubling time of renal cell carcinoma measured by CT: collaboration of Japanese Society of Renal Cancer. Jpn J Clin Oncol. 2004;34(2):82–5.
Rosenthal DI, Scott JA, Mankin HJ, Wismer GL, Brady TJ. Sacrococcygeal chordoma: magnetic resonance imaging and computed tomography. AJR. 1985;145(1):143–7.
Sze G, Uichanco LS 3rd, Brant-Zawadzki MN, Davis RL, Gutin PH, Wilson CB, et al. Chordomas: MR imaging. Radiology. 1988;166:187–91.
Rosai J. Chordoma. In: Ackerman’s surgical pathology. 8th ed. St. Louis, MO: Mosby; 1996. p. 1971–3.
Yakushiji T, Oka K, Sato H, Yorimitsu S, Fujimoto T, Yamashita Y, et al. Characterization of chondroblastic osteosarcoma: gadolinium-enhanced versus diffusion-weighted MR imaging. J Magn Reson Imaging. 2009;29(4):895–900.
Gerber S, Ollivier L, Leclere J, Vanel D, Missenard G, Brisse H, et al. Imaging of sacral tumours. Skelet Radiol. 2008;37(4):277–89.
Ibrahim T, Flamini E, Mercatali L, Sacanna E, Serra P, Amadori D. Pathogenesis of osteoblastic bone metastases from prostate cancer. Cancer. 2010;116(6):1406–18.
Charbit A, Malaise EP, Tubiana M. Relation between the pathological and the growth rate of human tumors. Eur J Cancer. 1971;7(4):307–15.
Zhang H, Yoshikawa K, Tamura K, Sagou K, Tian M, Suhara T, et al. Carbon-11-methionine positron emission tomography imaging of chordoma. Skelet Radiol. 2004;33(9):524–30.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Kishimoto, R., Omatsu, T., Hasegawa, A. et al. Imaging characteristics of metastatic chordoma. Jpn J Radiol 30, 509–516 (2012). https://doi.org/10.1007/s11604-012-0086-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11604-012-0086-3